[HTML][HTML] Vaccine adjuvants to engage the cross-presentation pathway
Adjuvants are indispensable components of vaccines for stimulating optimal immune
responses to non-replicating, inactivated and subunit antigens. Eliciting balanced humoral …
responses to non-replicating, inactivated and subunit antigens. Eliciting balanced humoral …
[HTML][HTML] Peptide-based vaccines for tuberculosis
W Gong, C Pan, P Cheng, J Wang, G Zhao… - Frontiers in …, 2022 - frontiersin.org
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. As a
result of the coronavirus disease 2019 (COVID-19) pandemic, the global TB mortality rate in …
result of the coronavirus disease 2019 (COVID-19) pandemic, the global TB mortality rate in …
[HTML][HTML] T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
Antigen-specific, MHC-restricted αβ T cells are necessary for protective immunity against
Mycobacterium tuberculosis, but the ability to broadly study these responses has been …
Mycobacterium tuberculosis, but the ability to broadly study these responses has been …
[HTML][HTML] A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
JS Woodworth, HS Clemmensen, H Battey… - Nature …, 2021 - nature.com
Given the encouraging clinical results of both candidate subunit vaccines and revaccination
with Bacillus Calmette-Guérin (BCG) against tuberculosis (TB), there is support for …
with Bacillus Calmette-Guérin (BCG) against tuberculosis (TB), there is support for …
[HTML][HTML] Therapeutic vaccines for tuberculosis: An overview
R Bouzeyen, B Javid - Frontiers in Immunology, 2022 - frontiersin.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis is the world's deadliest bacterial
infection, resulting in more than 1.4 million deaths annually. The emergence of drug …
infection, resulting in more than 1.4 million deaths annually. The emergence of drug …
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial
Background Tuberculosis is a major public health problem worldwide. Immunisation with
Mycobacterium bovis BCG vaccine is partially effective in infants, reducing the incidence of …
Mycobacterium bovis BCG vaccine is partially effective in infants, reducing the incidence of …
[PDF][PDF] CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection
YJ Lu, P Barreira-Silva, S Boyce, J Powers, K Cavallo… - Cell reports, 2021 - cell.com
CD4 T cells are essential for immunity to tuberculosis because they produce cytokines,
including interferon-γ. Whether CD4 T cells act as" helper" cells to promote optimal CD8 T …
including interferon-γ. Whether CD4 T cells act as" helper" cells to promote optimal CD8 T …
[HTML][HTML] Targeting innate immunity for tuberculosis vaccination
Vaccine development against tuberculosis (TB) is based on the induction of adaptive
immune responses endowed with long-term memory against mycobacterial antigens …
immune responses endowed with long-term memory against mycobacterial antigens …
[HTML][HTML] Vaccine development against tuberculosis over the last 140 years: Failure as part of success
SHE Kaufmann - Frontiers in Microbiology, 2021 - frontiersin.org
The year 2020 was shaped by the COVID-19 pandemic which killed more people than any
other infectious disease in this particular year. At the same time, the development of highly …
other infectious disease in this particular year. At the same time, the development of highly …
[HTML][HTML] Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Tuberculosis is the leading infectious disease killer globally due to a single pathogen.
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …